FMC
CRL icon

First Merchants Corp’s Charles River Laboratories CRL Stock Holding History

First Merchants Corp’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,491
Closed -$404K – 376
2024
Q1 		$404K Hold
1,491
– – 0.03% 182
2023
Q4 		$352K Hold
1,491
– – 0.03% 183
2023
Q3 		$292K Sell
1,491
-95
-6% -$19.5K 0.03% 186
2023
Q2 		$333K Sell
1,586
-485
-23% -$96.5K 0.03% 185
2023
Q1 		$418K Sell
2,071
-779
-27% -$177K 0.04% 183
2022
Q4 		$621K Sell
2,850
-3,215
-53% -$702K 0.06% 168
2022
Q3 		$1.19M Buy
6,065
+188
+3% +$40.6K 0.12% 152
2022
Q2 		$1.26M Sell
5,877
-727
-11% -$178K 0.12% 154
2022
Q1 		$1.88M Buy
6,604
+98
+2% +$30.2K 0.15% 141
2021
Q4 		$2.45M Sell
6,506
-145
-2% -$56.3K 0.19% 129
2021
Q3 		$2.75M Sell
6,651
-344
-5% -$143K 0.17% 119
2021
Q2 		$2.59M Buy
6,995
+148
+2% +$49.4K 0.17% 124
2021
Q1 		$1.98M Buy
6,847
+580
+9% +$161K 0.13% 139
2020
Q4 		$1.57M Sell
6,267
-564
-8% -$134K 0.11% 145
2020
Q3 		$1.55M Sell
6,831
-106
-2% -$22K 0.12% 139
2020
Q2 		$1.21M Sell
6,937
-61
-0.9% -$9.73K 0.1% 147
2020
Q1 		$883K Sell
6,998
-125
-2% -$18.7K 0.11% 159
2019
Q4 		$1.09M Sell
7,123
-234
-3% -$32.4K 0.11% 170
2019
Q3 		$974K Buy
+7,357
New +$986K 0.1% 175

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

First Merchants Corp's CRL Position: Q2 2024 in Review

First Merchants Corp sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 1,491 shares — an estimated $404K sold.

First Merchants Corp first reported a position in CRL in Q3 2019 and held it in 19 quarters. The position peaked at $2.75M in Q3 2021. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • First Merchants Corp reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • First Merchants Corp sold 1,491 Charles River Laboratories shares in Q2 2024, an estimated $404K.
  • First Merchants Corp first reported a position in Charles River Laboratories in Q3 2019 and held it in 19 quarters.
  • First Merchants Corp's Charles River Laboratories position peaked at $2.75M in Q3 2021.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on First Merchants Corp's 13F filing for Q2 2024, filed 25 Jul 2024.